7.32
+0.25(+3.54%)
Currency In USD
| Previous Close | 7.07 |
| Open | 7.17 |
| Day High | 7.41 |
| Day Low | 6.93 |
| 52-Week High | 14.38 |
| 52-Week Low | 6.02 |
| Volume | 441,056 |
| Average Volume | 431,638 |
| Market Cap | 485.74M |
| PE | -15.25 |
| EPS | -0.48 |
| Moving Average 50 Days | 6.74 |
| Moving Average 200 Days | 9.65 |
| Change | 0.25 |
If you invested $1000 in Bioventus Inc. (BVS) since IPO date, it would be worth $381.05 as of July 10, 2025 at a share price of $7.32. Whereas If you bought $1000 worth of Bioventus Inc. (BVS) shares 3 years ago, it would be worth $1,041.25 as of July 10, 2025 at a share price of $7.32.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Bioventus to Report First Quarter of Fiscal Year 2025 Financial Results on May 6, 2025
GlobeNewswire Inc.
Apr 28, 2025 12:00 PM GMT
DURHAM, N.C., April 28, 2025 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing, today announced that it will report financial results for the first quarter of fiscal y
Bioventus to Report Fourth Quarter of Fiscal Year 2024 Financial Results on March 11, 2025
GlobeNewswire Inc.
Feb 28, 2025 12:30 PM GMT
DURHAM, N.C., Feb. 28, 2025 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing, today announced that it will report financial results for the fourth quarter of fiscal y
Bioventus to Present at the 43rd Annual J.P. Morgan Healthcare Conference
GlobeNewswire Inc.
Jan 07, 2025 1:00 PM GMT
DURHAM, N.C., Jan. 07, 2025 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS), a global leader in innovations for active healing, today announced that Rob Claypoole, chief executive officer, will present at the 43rd Annual J.P. Morgan Healthcare Con